Also, there are accumulating evidences that overexpression of cell survival or anti-apoptotic proteins such as Bcl-2, and Bcl-xL contributes to TRAIL resistance in cancer cells [43] and TRAIL induces apoptosis by binding to its cell surface death receptors such as DR4 and DR5 [44]. The gene discussed is BCL2; the disease is cancer.